The issuer advises that the following replaces the ECO Animal Health Group plc 'Director/PDMR Shareholding' announcement released at 09.20 am GMT on February 18, 2015.
The announcement released on 18th February 2015 at 9.20 a.m. contained an omission error. The announcement should have also stated that the Board granted 30,000 new options to Anthony Rawlinson, a director of the company, under the Company’s executive share option scheme. These options will vest on 13th February 2018.
All other details remain unchanged.
The full corrected version is shown below.
Correction - Issue of Share Options
ECO Animal Health Group plc
(“ECO” or the “Company”)
11 March 2015
The Company announces that on 13th February 2015, the Board granted new options to certain Directors of the Company under the Company’s executive share option scheme. The options will vest on 13th February 2018 and have been granted as follows:
|Director||Number of options granted||Exercise price|
The Company’s total issued share capital with voting rights remains 63,107,421 ordinary shares of 5p each, with one voting right per share.
|ECO Animal Health Group plc|
|Peter Lawrence, Executive Chairman||020 8336 6190|
|Marc Loomes, CEO||020 8447 8899|
|Anthony Spiro||020 8336 6196|
|Peel Hunt LLP (Nominated Adviser)|
|Dan Webster, Richard Brown, Dan Harris||020 7418 8900|
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
Eco Animal Health Group Plc